Liver disease, HIV and aging

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


The life expectancy of HIV-infected patients has increased due to the efficacy of highly active antiretroviral therapy (HAART) in controlling HIV replication; thus, the population living with HIV infection is steadily aging. Liver-related morbidity and mortality has emerged as a leading problem in HIV-infected patients. Since aging, HIV infection and HAART all affect the liver, understanding the impact of the combination of these factors on liver disease is crucial for optimisation of care in the aging HIV-infected population. This review will focus on the current understanding of liver disease in older (>50 years old) HIV-negative individuals and in HIV-infected individuals. Areas for future research in the area of HIV, liver disease and aging will also be discussed.

Original languageEnglish (US)
Pages (from-to)512-520
Number of pages9
JournalSexual Health
Issue number4
StatePublished - 2011


  • cirrhosis
  • hepatitis
  • highly active antiretroviral therapy

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'Liver disease, HIV and aging'. Together they form a unique fingerprint.

Cite this